Chavita 3

Argentum Met, Chamomilla, Chelidonium Majus, Nux Vomica, Pancreas Suis, Lycopodium, Zingiber


Rubimed Ag
Human Otc Drug
NDC 66343-120
Chavita 3 also known as Argentum Met, Chamomilla, Chelidonium Majus, Nux Vomica, Pancreas Suis, Lycopodium, Zingiber is a human otc drug labeled by 'Rubimed Ag'. National Drug Code (NDC) number for Chavita 3 is 66343-120. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Chavita 3 drug includes Chelidonium Majus Whole - 21 [hp_X]/60mL Ginger - 21 [hp_X]/60mL Lycopodium Clavatum Spore - 200 [hp_C]/60mL Matricaria Chamomilla Whole - 21 [hp_X]/60mL Silver - 21 [hp_X]/60mL Strychnos Nux-vomica Seed - 50 [kp_C]/60mL Sus Scrofa Pancreas - 21 [hp_X]/60mL . The currest status of Chavita 3 drug is Active.

Drug Information:

Drug NDC: 66343-120
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Chavita 3
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Argentum Met, Chamomilla, Chelidonium Majus, Nux Vomica, Pancreas Suis, Lycopodium, Zingiber
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Rubimed Ag
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CHELIDONIUM MAJUS WHOLE - 21 [hp_X]/60mL
GINGER - 21 [hp_X]/60mL
LYCOPODIUM CLAVATUM SPORE - 200 [hp_C]/60mL
MATRICARIA CHAMOMILLA WHOLE - 21 [hp_X]/60mL
SILVER - 21 [hp_X]/60mL
STRYCHNOS NUX-VOMICA SEED - 50 [kp_C]/60mL
SUS SCROFA PANCREAS - 21 [hp_X]/60mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Dec, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 16 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:RUBIMED AG
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
NUI:N0000185375
N0000185371
N0000175629
N0000184306
M0000728
M0006342
M0016962
M0008672
N0000185001
M0516536
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:7E889U5RNN
C5529G5JPQ
C88X29Y479
G0R4UBI2ZZ
3M4G523W1G
269XH13919
9Y3J3362RY
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:Non-Standardized Plant Allergenic Extract [EPC]
Non-Standardized Food Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:Increased Histamine Release [PE]
Cell-mediated Immunity [PE]
Increased IgG Production [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:Allergens [CS]
Dietary Proteins [CS]
Plant Proteins [CS]
Food Additives [CS]
Seed Storage Proteins [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:Allergens [CS]
Cell-mediated Immunity [PE]
Dietary Proteins [CS]
Food Additives [CS]
Increased Histamine Release [PE]
Increased IgG Production [PE]
Non-Standardized Food Allergenic Extract [EPC]
Non-Standardized Plant Allergenic Extract [EPC]
Plant Proteins [CS]
Seed Storage Proteins [CS]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
66343-120-6060 mL in 1 BOTTLE (66343-120-60)19 Dec, 2022N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Homeopathic medicine for nausea and acid stomach

Product Elements:

Chavita 3 argentum met, chamomilla, chelidonium majus, nux vomica, pancreas suis, lycopodium, zingiber silver silver matricaria chamomilla whole matricaria chamomilla chelidonium majus whole chelidonium majus strychnos nux-vomica seed strychnos nux-vomica seed sus scrofa pancreas sus scrofa pancreas lycopodium clavatum spore lycopodium clavatum spore ginger ginger alcohol water

Indications and Usage:

Uses: (†) homeopathic remedy for nausea and acid stomach.

Warnings:

Warnings: stop use if symptoms persist or worsen. if you are pregnant or breastfeeding, consult a healthcare professional prior to use. keep out of reach of children.

Dosage and Administration:

Directions: (adults & children 6 years & older) take 12 drops 2 times daily, or as recommended by your health care professional.

Package Label Principal Display Panel:

Ndc 66343-120-60 rubimed chavita 3 homeopathic medicine for nausea and stomach acid 2.0 fl oz. 59ml 20% ethanol homeopathic medicine for nausea and acid stomach chavita 3 - label chavita 3 - carton

Further Questions:

Manufactured by: ohm pharma, inc, usa. distributed by: privia naturals, llc. 9169 w state st #196 garden city, id 83714 www.privianaturals.com info@privianaturals.com product of usa.


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.